Pediatric multiple sclerosis: current concepts and consensus definitions.

Area of Science:

• Neurology
• Immunology
• Pediatrics

Background:

• Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease affecting the central nervous system (CNS).
• While typically diagnosed in adults, MS is increasingly recognized in pediatric populations, accounting for 1.7%-5.6% of cases before age 18.
• Diagnosing MS in children presents challenges due to potential misdiagnosis and distinct clinical presentations compared to adults.

Purpose of the Study:

• To describe the distinctive features of pediatric demyelinating disorders, including MS.
• To summarize recent advances in the diagnosis and understanding of pediatric MS.
• To review the applicability of diagnostic criteria for childhood MS.

Main Methods:

• Literature review of recent advances in pediatric demyelinating disorders.
• Analysis of distinctive clinical, neuroimaging, and laboratory features in pediatric MS.
• Evaluation of diagnostic criteria, including the 2010 McDonald criteria, for pediatric MS.

Main Results:

• Pediatric MS exhibits unique clinical features, neuroimaging findings, laboratory results, and disease courses compared to adult MS.
• The 2010 McDonald criteria are proposed for diagnosing MS in children aged 12 and older.
• Accurate diagnosis in children can be challenging, often requiring differentiation from other neurological disorders.

Conclusions:

• Pediatric MS is a distinct entity with specific characteristics requiring tailored diagnostic approaches.
• Recent advances and updated criteria aid in the diagnosis of MS in children.
• Further research is needed to fully understand and manage pediatric demyelinating disorders.